Doxycycline

Product NDC: 42783-601
11-digit product format: 427830601
Labeler code: 42783
Product ID: 42783-601_881b762a-b1e5-436c-800a-0f058967d0a8
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Doxycycline
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Elorac, Inc.
Application: ANDA065285
Marketing category: ANDA
Marketing start: 2005-12-08
Marketing end: 0000-00-00
Substance: DOXYCYCLINE
Active strength: 100 mg/1
Pharmacologic classes: Tetracycline-class Drug [EPC],Tetracyclines [CS]
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 7 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	42783-601		D	Discontinued by firm	2026-08-17
excluded product	product	42783-601		I	Inactivated by FDA	2026-08-17
excluded product	product	42783-601		I	Inactivated by FDA	2026-08-17
excluded package	package	42783-601	42783-601-30	D	Discontinued by firm	2026-08-17
excluded package	package	42783-601	42783-601-60	D	Discontinued by firm	2026-08-17
excluded package	package	42783-601	42783-601-30	I	Inactivated by FDA	2026-08-17
excluded package	package	42783-601	42783-601-60	I	Inactivated by FDA	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 3 · 124 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	42783-601-60	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	42783-601-60	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	42783-601-30	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	42783-601-30	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	42783-601-60	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	42783-601-60	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	42783-601-30	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	42783-601-30	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	42783-601-60	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	42783-601-60	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	42783-601-30	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	42783-601-30	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	42783-601-60	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	42783-601-60	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	42783-601-30	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	42783-601-30	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	42783-601-60	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	42783-601-60	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	42783-601-30	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	42783-601-30	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	42783-601-60	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	42783-601-60	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	42783-601-30	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	42783-601-30	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	42783-601-60	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	42783-601-60	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	42783-601-30	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	42783-601-30	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	42783-601-60	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	42783-601-60	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	42783-601-30	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	42783-601-30	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	42783-601-60	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A065285-001	DOXYCYCLINE	DOXYCYCLINE	EQ 50MG BASE	TABLET / ORAL	AB	2005-12-08
A065285-002	DOXYCYCLINE	DOXYCYCLINE	EQ 100MG BASE	TABLET / ORAL	AB	2005-12-08
A065285-003	DOXYCYCLINE	DOXYCYCLINE	EQ 75MG BASE	TABLET / ORAL	AB	2008-07-30
A065285-004	DOXYCYCLINE	DOXYCYCLINE	EQ 150MG BASE	TABLET / ORAL	AB	2008-07-30

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
A065285-001	AB
A065285-002	AB
A065285-003	AB
A065285-004	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 168 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A065285-001	DOXYCYCLINE	EQ 50MG BASE	TABLET / ORAL	AB	2005-12-08	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065285-002	DOXYCYCLINE	EQ 100MG BASE	TABLET / ORAL	AB	2005-12-08	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065285-003	DOXYCYCLINE	EQ 75MG BASE	TABLET / ORAL	AB	2008-07-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065285-004	DOXYCYCLINE	EQ 150MG BASE	TABLET / ORAL	AB	2008-07-30	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A065285-001	DOXYCYCLINE	EQ 50MG BASE	TABLET / ORAL	AB	2005-12-08	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065285-002	DOXYCYCLINE	EQ 100MG BASE	TABLET / ORAL	AB	2005-12-08	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065285-003	DOXYCYCLINE	EQ 75MG BASE	TABLET / ORAL	AB	2008-07-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065285-004	DOXYCYCLINE	EQ 150MG BASE	TABLET / ORAL	AB	2008-07-30	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065285-001	DOXYCYCLINE	EQ 50MG BASE	TABLET / ORAL	AB	2005-12-08	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065285-002	DOXYCYCLINE	EQ 100MG BASE	TABLET / ORAL	AB	2005-12-08	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065285-003	DOXYCYCLINE	EQ 75MG BASE	TABLET / ORAL	AB	2008-07-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065285-004	DOXYCYCLINE	EQ 150MG BASE	TABLET / ORAL	AB	2008-07-30	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065285-001	DOXYCYCLINE	EQ 50MG BASE	TABLET / ORAL	AB	2005-12-08	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065285-002	DOXYCYCLINE	EQ 100MG BASE	TABLET / ORAL	AB	2005-12-08	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065285-003	DOXYCYCLINE	EQ 75MG BASE	TABLET / ORAL	AB	2008-07-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065285-004	DOXYCYCLINE	EQ 150MG BASE	TABLET / ORAL	AB	2008-07-30	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065285-001	DOXYCYCLINE	EQ 50MG BASE	TABLET / ORAL	AB	2005-12-08	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065285-002	DOXYCYCLINE	EQ 100MG BASE	TABLET / ORAL	AB	2005-12-08	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065285-003	DOXYCYCLINE	EQ 75MG BASE	TABLET / ORAL	AB	2008-07-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065285-004	DOXYCYCLINE	EQ 150MG BASE	TABLET / ORAL	AB	2008-07-30	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065285-001	DOXYCYCLINE	EQ 50MG BASE	TABLET / ORAL	AB	2005-12-08	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065285-002	DOXYCYCLINE	EQ 100MG BASE	TABLET / ORAL	AB	2005-12-08	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065285-003	DOXYCYCLINE	EQ 75MG BASE	TABLET / ORAL	AB	2008-07-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065285-004	DOXYCYCLINE	EQ 150MG BASE	TABLET / ORAL	AB	2008-07-30	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065285-001	DOXYCYCLINE	EQ 50MG BASE	TABLET / ORAL	AB	2005-12-08	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065285-002	DOXYCYCLINE	EQ 100MG BASE	TABLET / ORAL	AB	2005-12-08	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065285-003	DOXYCYCLINE	EQ 75MG BASE	TABLET / ORAL	AB	2008-07-30	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065285-004	DOXYCYCLINE	EQ 150MG BASE	TABLET / ORAL	AB	2008-07-30	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065285-001	DOXYCYCLINE	EQ 50MG BASE	TABLET / ORAL	AB	2005-12-08	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065285-002	DOXYCYCLINE	EQ 100MG BASE	TABLET / ORAL	AB	2005-12-08	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065285-003	DOXYCYCLINE	EQ 75MG BASE	TABLET / ORAL	AB	2008-07-30	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065285-004	DOXYCYCLINE	EQ 150MG BASE	TABLET / ORAL	AB	2008-07-30	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065285-001	DOXYCYCLINE	EQ 50MG BASE	TABLET / ORAL	AB	2005-12-08	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065285-002	DOXYCYCLINE	EQ 100MG BASE	TABLET / ORAL	AB	2005-12-08	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065285-003	DOXYCYCLINE	EQ 75MG BASE	TABLET / ORAL	AB	2008-07-30	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065285-004	DOXYCYCLINE	EQ 150MG BASE	TABLET / ORAL	AB	2008-07-30	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065285-001	DOXYCYCLINE	EQ 50MG BASE	TABLET / ORAL	AB	2005-12-08	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065285-002	DOXYCYCLINE	EQ 100MG BASE	TABLET / ORAL	AB	2005-12-08	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065285-003	DOXYCYCLINE	EQ 75MG BASE	TABLET / ORAL	AB	2008-07-30	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065285-004	DOXYCYCLINE	EQ 150MG BASE	TABLET / ORAL	AB	2008-07-30	`d8e5a09893c0…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 168 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A065285-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065285-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065285-003	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065285-004	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A065285-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065285-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065285-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065285-004	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065285-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065285-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065285-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065285-004	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065285-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065285-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065285-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065285-004	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065285-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065285-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065285-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065285-004	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065285-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065285-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065285-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065285-004	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065285-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065285-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065285-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065285-004	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065285-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065285-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065285-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065285-004	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065285-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065285-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065285-003	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065285-004	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065285-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065285-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065285-003	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065285-004	AB	1	`d8e5a09893c0…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
b4321c75-2e87-4d90-9726-9a28fb2293a3	Product name	3	20260112
a46239a7-5963-4008-8cbb-6b9000f497eb	Product name	1	20250721
b382b4e1-6b48-45f6-bffc-e61b00b0ce19	Product name	3	20250317
5e99724e-0654-4aec-b7a2-0b9b10e312ee	Product name	3	20250227
d9d61457-6a5a-41fc-b418-e5479a2904b7	Product name	2	20230303
32012d5c-25ac-49c7-9d4c-1313177fff7c	Product name	1	20230112
d2d36660-68ce-7e7d-0630-ec4b0d859fad	Product name	6	20220921
13e7e7e3-e885-4c79-af6d-dad1aedbb06e	Product name	1	20220128
4a7d44fe-774d-404b-aad0-8a90fe78375a	Product name	4	20211025
a239f4dd-cf93-4660-b190-f97d000f249f	Product name	7	20210607
a9d03566-caeb-4466-8021-74599b048880	Product name	3	20210604
12750814-20f7-4f35-b5fa-dbc8811ba858	Product name	9	20201007
00a5dbaa-1b7d-4e56-be0c-fedc7bbf5ade	Product name	1	20200706
3f45980c-c196-47e5-0e5e-48b7c57327c5	Product name	5	20200428
d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27b	Product name	3	20200203
ee5c6de5-d9cd-454f-b250-7b19e5cf2992	Product name	4	20190619
7b4b06ac-8c50-45f0-9556-293ea558a294	Product name	1	20180808
6a5b4392-5ab0-af0d-e0be-47b34e9dbb84	Product name	5	20171121
01a4aa74-7e05-63bd-bc10-1b5ceb111371	Product name	2	20171115
ad75fcfd-a339-42a1-9c60-43ba2c654cfa	Product name	1	20170810
58b1278c-6dce-49b6-a05e-ea16f389acba	Product name	1	20160620

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
42783-601-30	2020-01-31	C162847	48780-1	9d75b9d0-4ed0-f424-e053-dadaa90a57ce	Doxycycline Tablets, USP
42783-601-60	2020-01-31	C162847	48780-1	9d75b9d0-4e9a-f424-e053-dadaa90a57ce	Doxycycline Tablets, USP

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
42783-601-60	Doxycycline	60 in 1 BOTTLE	TABLET, FILM COATED	60		11
42783-601-30	Doxycycline	30 in 1 BOTTLE	TABLET, FILM COATED	30		7

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
DOXYCYCLINE	ACTIVE INGREDIENT	N12000U13O	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	11
DOXYCYCLINE ANHYDROUS	ACTIVE MOIETY	334895S862	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	11
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	11
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	11
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	11
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	11
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	11
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	11
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	11
POLYVINYL ALCOHOL	INACTIVE INGREDIENT	532B59J990	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	11
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	11
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	11
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	11
DOXYCYCLINE	ACTIVE INGREDIENT	N12000U13O	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	7
DOXYCYCLINE ANHYDROUS	ACTIVE MOIETY	334895S862	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	7
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	7
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	7
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	7
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	7
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	7
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	7
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	7
POLYVINYL ALCOHOL	INACTIVE INGREDIENT	532B59J990	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	7
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	7
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	7
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	7
BENZOYL PEROXIDE	ACTIVE INGREDIENT	W9WZN9A0GM	BENZODOX 30 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	4
DOXYCYCLINE	ACTIVE INGREDIENT	N12000U13O	BENZODOX 30 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	4
BENZOYL PEROXIDE	ACTIVE MOIETY	W9WZN9A0GM	BENZODOX 30 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	4
DOXYCYCLINE ANHYDROUS	ACTIVE MOIETY	334895S862	BENZODOX 30 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	4
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	BENZODOX 30 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	4
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	BENZODOX 30 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	4
C13-14 ISOPARAFFIN	INACTIVE INGREDIENT	E4F12ROE70	BENZODOX 30 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	4
CANDELILLA WAX	INACTIVE INGREDIENT	WL0328HX19	BENZODOX 30 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	4
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	BENZODOX 30 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	4
COCAMIDOPROPYL BETAINE	INACTIVE INGREDIENT	5OCF3O11KX	BENZODOX 30 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	4
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	BENZODOX 30 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	4
ETHYLHEXYLGLYCERIN	INACTIVE INGREDIENT	147D247K3P	BENZODOX 30 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	4
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	BENZODOX 30 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	4
HYDROXYETHYL BEHENAMIDOPROPYL DIMONIUM CHLORIDE	INACTIVE INGREDIENT	9CO8OUL4TH	BENZODOX 30 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	4
LAURETH-7	INACTIVE INGREDIENT	Z95S6G8201	BENZODOX 30 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	4
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	BENZODOX 30 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	4
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	BENZODOX 30 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	4
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	BENZODOX 30 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	4
POLYVINYL ALCOHOL	INACTIVE INGREDIENT	532B59J990	BENZODOX 30 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	4
SHEA BUTTER	INACTIVE INGREDIENT	K49155WL9Y	BENZODOX 30 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	4
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	BENZODOX 30 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	4
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	BENZODOX 30 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	4
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	BENZODOX 30 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	4
WATER	INACTIVE INGREDIENT	059QF0KO0R	BENZODOX 30 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	4
BENZOYL PEROXIDE	ACTIVE INGREDIENT	W9WZN9A0GM	BENZODOX 60 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	2
DOXYCYCLINE	ACTIVE INGREDIENT	N12000U13O	BENZODOX 60 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	2
BENZOYL PEROXIDE	ACTIVE MOIETY	W9WZN9A0GM	BENZODOX 60 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	2
DOXYCYCLINE ANHYDROUS	ACTIVE MOIETY	334895S862	BENZODOX 60 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	2
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	BENZODOX 60 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	2
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	BENZODOX 60 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	2
C13-14 ISOPARAFFIN	INACTIVE INGREDIENT	E4F12ROE70	BENZODOX 60 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	2
CANDELILLA WAX	INACTIVE INGREDIENT	WL0328HX19	BENZODOX 60 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	BENZODOX 60 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	2
COCAMIDOPROPYL BETAINE	INACTIVE INGREDIENT	5OCF3O11KX	BENZODOX 60 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	2
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	BENZODOX 60 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	2
ETHYLHEXYLGLYCERIN	INACTIVE INGREDIENT	147D247K3P	BENZODOX 60 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	2
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	BENZODOX 60 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	2
HYDROXYETHYL BEHENAMIDOPROPYL DIMONIUM CHLORIDE	INACTIVE INGREDIENT	9CO8OUL4TH	BENZODOX 60 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	2
LAURETH-7	INACTIVE INGREDIENT	Z95S6G8201	BENZODOX 60 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	BENZODOX 60 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	2
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	BENZODOX 60 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	2
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	BENZODOX 60 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	2
POLYVINYL ALCOHOL	INACTIVE INGREDIENT	532B59J990	BENZODOX 60 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	2
SHEA BUTTER	INACTIVE INGREDIENT	K49155WL9Y	BENZODOX 60 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	BENZODOX 60 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	2
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	BENZODOX 60 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	BENZODOX 60 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	BENZODOX 60 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
42783-601	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	11	Legacy NDC, 1 package rows	20151015_3e526226-0ac6-4357-af89-23639e23ef58.zip
42783-601	DOXYCYCLINE TABLET, FILM COATED [ELORAC, INC.]	7	Legacy NDC, 1 package rows	20151015_d9229004-5d44-4d36-a3ba-4d8826b143f1.zip
42783-601	BENZODOX 30 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	4	Legacy NDC	20151030_ddd9a47e-7d7c-4d0c-aaa6-32702570f696.zip
42783-601	BENZODOX 60 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]	2	Legacy NDC	20151017_92ab3004-f719-4861-ba6a-c93ec9ab94f4.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Doxycycline	DOXYCYCLINE	American Health Packaging	adc6ba78-8dd7-47af-a7b4-c2215557696b	2025-01-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065285 application number: ANDA065285
Doxycycline	DOXYCYCLINE	Bryant Ranch Prepack	5f22094e-9297-4d1b-a37c-7846481b321e	2024-08-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065285 application number: ANDA065285
Doxycycline	DOXYCYCLINE	Lannett Company, Inc.	4999bbd9-44ed-4749-9730-be2337bdf490	2024-07-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065285 application number: ANDA065285

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
N12000U13O	DOXYCYCLINE	17086-28-1	DOXYCYCLINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1650142	doxycycline monohydrate 100 MG Oral Tablet	PSN	3e526226-0ac6-4357-af89-23639e23ef58	11
1650142	doxycycline monohydrate 100 MG Oral Tablet	SCD	3e526226-0ac6-4357-af89-23639e23ef58	11
1650142	doxycycline monohydrate 100 MG Oral Tablet	PSN	d9229004-5d44-4d36-a3ba-4d8826b143f1	7
1650142	doxycycline monohydrate 100 MG Oral Tablet	SCD	d9229004-5d44-4d36-a3ba-4d8826b143f1	7
1543390	benzoyl peroxide 4.4 % Medicated Liquid Soap	PSN	ddd9a47e-7d7c-4d0c-aaa6-32702570f696	4
1650142	doxycycline monohydrate 100 MG Oral Tablet	PSN	ddd9a47e-7d7c-4d0c-aaa6-32702570f696	4
1543390	benzoyl peroxide 44 MG/ML Medicated Liquid Soap	SCD	ddd9a47e-7d7c-4d0c-aaa6-32702570f696	4
1650142	doxycycline monohydrate 100 MG Oral Tablet	SCD	ddd9a47e-7d7c-4d0c-aaa6-32702570f696	4
1543390	benzoyl peroxide 4.4 % Medicated Liquid Soap	SY	ddd9a47e-7d7c-4d0c-aaa6-32702570f696	4
1543390	benzoyl peroxide 4.4 % Medicated Liquid Soap	PSN	92ab3004-f719-4861-ba6a-c93ec9ab94f4	2
1650142	doxycycline monohydrate 100 MG Oral Tablet	PSN	92ab3004-f719-4861-ba6a-c93ec9ab94f4	2
1543390	benzoyl peroxide 44 MG/ML Medicated Liquid Soap	SCD	92ab3004-f719-4861-ba6a-c93ec9ab94f4	2
1650142	doxycycline monohydrate 100 MG Oral Tablet	SCD	92ab3004-f719-4861-ba6a-c93ec9ab94f4	2
1543390	benzoyl peroxide 4.4 % Medicated Liquid Soap	SY	92ab3004-f719-4861-ba6a-c93ec9ab94f4	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
42783-601-30	42783060130	30 in 1 BOTTLE	Historical
42783-601-60	42783060160	60 in 1 BOTTLE	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
BenzoDox TM 30 Kit	Elorac, Inc.	2015-10-20	HUMAN PRESCRIPTION DRUG LABEL	4
BenzoDox TM 60 Kit	Elorac, Inc.	2015-10-16	HUMAN PRESCRIPTION DRUG LABEL	2
Doxycycline Tablets, USP	Elorac, Inc.	2015-10-08	HUMAN PRESCRIPTION DRUG LABEL	11
Doxycycline Tablets, USP	Elorac, Inc.	2015-10-08	HUMAN PRESCRIPTION DRUG LABEL	7